NU SKIN ENTERPRISES, INC. (NUS) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — NUS

Balance Sheet

(in billions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	0.19	0.20	0.25	0.26	0.20	0.23	0.22	0.21	0.23	0.24	0.23	0.29	0.36	0.30	0.28	0.35	0.34
Short-term Investments	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.01	0.02	0.02	0.02	0.02	0.02
Accounts Receivable	0.05	0.05	0.05	0.06	0.06	0.07	0.07	0.07	0.08	0.07	0.06	0.05	0.04	0.05	0.05	0.06	0.06
Inventory	0.19	0.18	0.18	0.18	0.19	0.25	0.24	0.27	0.29	0.37	0.37	0.33	0.35	0.38	0.42	0.39	0.36
Total Current Assets	0.51	0.52	0.55	0.57	0.52	0.65	0.65	0.65	0.70	0.79	0.77	0.78	0.88	0.85	0.89	0.96	0.90
Property, Plant & Equipment	0.38	0.38	0.38	0.37	0.38	0.41	0.41	0.42	0.43	0.43	0.44	0.43	0.44	0.45	0.46	0.47	0.46
Goodwill	0.00	0.08	0.08	0.08	0.08	0.10	0.10	0.23	0.23	0.23	0.21	0.21	0.21	0.21	0.22	0.22	0.20
Intangible Assets	0.04	0.04	0.04	0.05	0.05	0.09	0.09	0.10	0.11	0.11	0.06	0.07	0.07	0.07	0.09	0.10	0.09
Total Non-current Assets*	0.61	0.85	0.88	0.87	0.87	0.93	0.93	1.09	1.09	1.10	1.05	0.99	1.02	1.04	1.08	1.09	1.05
Total Assets	1.12	1.38	1.42	1.44	1.39	1.58	1.59	1.74	1.79	1.89	1.82	1.76	1.90	1.89	1.97	2.05	1.95
Accounts Payable	0.04	0.03	0.03	0.03	0.03	0.03	0.04	0.03	0.05	0.05	0.05	0.04	0.06	0.04	0.05	0.06	0.07
Total Current Liabilities	0.26	0.26	0.25	0.28	0.26	0.34	0.31	0.31	0.43	0.45	0.37	0.37	0.38	0.49	0.54	0.62	0.56
Long-term Debt	0.19	0.20	0.21	0.21	0.22	0.37	0.43	0.45	0.36	0.37	0.37	0.38	0.39	0.26	0.28	0.29	0.30
Total Non-current Liabilities*	0.32	0.33	0.37	0.37	0.38	0.54	0.59	0.62	0.54	0.55	0.56	0.56	0.58	0.46	0.50	0.52	0.52
Total Liabilities	0.58	0.58	0.62	0.66	0.64	0.88	0.90	0.93	0.97	1.00	0.93	0.92	0.96	0.96	1.04	1.13	1.08
Retained Earnings	1.61	1.86	1.85	1.83	1.82	1.75	1.75	1.87	1.88	1.94	1.93	1.90	1.95	1.93	1.94	1.91	1.87
Total Stockholder Equity	0.54	0.79	0.80	0.79	0.75	0.71	0.69	0.81	0.82	0.90	0.89	0.84	0.94	0.93	0.94	0.92	0.87

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	320.11	320.61	370.32	364.21	386.14	364.49	445.55	430.15	439.08	417.31	488.64	498.77	500.26	481.46	522.34	537.80	560.62	604.90	673.44	641.15
Cost of Revenue	101.79	106.15	108.34	107.49	120.41	117.53	166.41	128.68	131.90	123.24	136.22	206.51	135.54	133.59	147.82	173.50	148.10	161.50	173.78	158.91
Gross Profit	218.33	214.46	261.98	256.72	265.73	246.96	279.15	301.46	307.18	294.06	352.43	292.27	364.72	347.87	374.52	364.31	412.52	443.40	499.66	482.25
Selling, General & Admin	90.85	98.54	107.40	104.82	106.73	113.20	120.93	115.62	117.92	124.57	145.03	130.88	137.04	133.90	127.66	137.99	141.56	148.56	166.64	161.14
Total Operating Expenses	277.64	210.44	238.74	235.08	234.95	256.86	332.23	283.23	432.73	285.24	336.36	318.63	322.21	331.81	347.07	384.59	360.99	391.26	479.34	416.86
Operating Income	(59.32)	4.03	23.24	21.64	30.78	(9.90)	(53.08)	18.23	(125.56)	8.82	16.06	(26.36)	42.51	16.06	27.46	(20.28)	51.53	52.15	20.32	65.38
Interest Expense	--	--	--	--	--	--	--	6.50	6.72	7.33	7.41	--	--	--	--	--	--	--	--	--
Pretax Income	(63.17)	2.60	18.19	15.99	27.41	134.60	(57.80)	13.30	(131.65)	1.10	9.33	(34.45)	37.11	14.59	24.36	(28.96)	42.89	50.69	18.43	68.17
Tax Provision	186.62	0.76	3.70	(1.08)	6.29	27.09	(21.70)	5.00	(13.39)	1.63	2.05	2.50	10.22	3.21	(32.86)	(3.57)	8.65	11.98	27.67	18.44
Net Income	(249.80)	1.84	14.49	17.08	21.12	107.52	(36.10)	8.30	(118.26)	(0.53)	7.28	(36.95)	26.89	11.38	57.22	(25.39)	34.24	38.72	(9.23)	49.73
Basic EPS	(5.14)	0.04	0.31	0.35	0.43	2.16	(0.73)	0.17	(2.38)	(0.01)	0.14	(0.74)	0.54	0.23	1.16	(0.51)	0.68	0.77	(0.18)	0.99
Diluted EPS	(5.14)	0.04	0.27	0.34	0.43	2.14	(0.73)	0.17	(2.38)	(0.01)	0.14	(0.74)	0.54	0.23	1.15	(0.51)	0.67	0.76	(0.17)	0.97

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	10.63	(3.92)	16.62	27.48	35.80	0.39	25.79	31.43	51.21	3.32	54.17	51.03	35.52	(22.08)	25.53	28.44	46.56	7.54	109.51	30.21
Capital Expenditures	5.64	13.71	10.76	9.91	0.02	13.58	12.58	8.60	8.12	12.28	20.39	11.91	14.71	11.49	13.78	25.46	9.54	10.28	18.23	13.54
Free Cash Flow*	4.99	(17.63)	5.86	17.57	35.78	(13.19)	13.20	22.84	43.08	(8.96)	33.78	39.12	20.81	(33.56)	11.74	2.99	37.02	(2.74)	91.28	16.68
Investing Cash Flow	(5.64)	(14.29)	(9.76)	(9.91)	8.79	181.54	(13.62)	(6.55)	(8.53)	(9.26)	(15.40)	(11.91)	(92.50)	(14.70)	(13.38)	(25.21)	(18.35)	(10.13)	(15.58)	(17.91)
Financing Cash Flow	(13.38)	(20.40)	(18.50)	(26.88)	9.27	(166.29)	(43.63)	(28.78)	(28.82)	(31.95)	(20.26)	(38.37)	67.99	1.38	(50.79)	(61.11)	46.16	(33.76)	(35.92)	(80.02)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q2 2014	Q1 2014	Q2 2013	Q1 2013	Q3 2012	Q2 2012	Q1 2012	Q3 2011	Q2 2011
Dividends Per Share	0.35	0.35	0.30	0.30	0.20	0.20	0.20	0.14	0.14